Gundu HR Rao*
Emeritus Professor, Laboratory Medicine and Pathology, Director, Thrombosis Research, Lillehei Heart Institute, University of Minnesota, USA
*Corresponding Author: Gundu HR Rao, Emeritus Professor, Laboratory Medicine and Pathology, Director, Thrombosis Research, Lillehei Heart Institute, University of Minnesota, USA.
Received: June 01, 2020; Published: July 31, 2020
Severe acute respiratory virus syndrome causing virus, coronavirus 2019 (SARS CoV-2), has caused unprecedented health and economic crisis worldwide. Coronavirus disease (COVDO-19), has caused more death in the USA in the last hundred days, than the wars that the US has fought in this century. It has exceeded, the annual death records of last several decades, by the influenza virus. The genome size of this virus ranges between 27 and 34 kilobases, larger than most other RNA viruses.
Citation: Gundu HR Rao. “COVID-19; Pharmacological Approaches for Infection Prevention: Old and the New".Acta Scientific Pharmacology 1.8 (2020): 33-37.
Copyright: © 2020 Gundu HR Rao. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.